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Abstract Pre- and postnatal corticosteroids are often
used in perinatal medicine to improve pulmonary function
in preterm infants. To mimic this clinical situation, new-
born rats were treated systemically with dexamethasone
(Dex), 0.1–0.01 mg/kg/day on days P1–P4. We hypothe-
sized that postnatal Dex may have an impact on alveolar-
ization by interfering with extracellular matrix proteins and
cellular differentiation. Morphological alterations were
observed on 3D images obtained by high-resolution syn-
chrotron radiation X-ray tomographic microscopy. Alveo-
larization was quantified stereologically by estimating the
formation of new septa between days P4 and P60. The
parenchymal expression of tenascin-C (TNC), smooth
muscle actin (SMA), and elastin was measured by immu-
nofluorescence and gene expression for TNC by qRT-PCR.
After Dex treatment, the first phase of alveolarization was
significantly delayed between days P6 and P10, whereas
the second phase was accelerated. Elastin and SMA
expressions were delayed by Dex treatment, whereas TNC
expression was delayed and prolonged. A short course of
neonatal steroids impairs the first phase of alveolarization,
most likely by altering the TNC and elastin expression.
Due to an overshooting catch-up during the second phase
of alveolarization, the differences disappear when the
animals reach adulthood.
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Introduction
Since Liggins and Howie have shown a beneficial effect on
survival of preterm infants after prenatal steroid adminis-
tration to their mothers, glucocorticoid treatment has
become a standard in modern perinatal medicine (Liggins
and Howie 1972). Postnatal steroid treatment of ventilated
preterm infants has been shown to improve gas exchange,
to shorten the duration of ventilator dependency and to
reduce the risk of developing chronic lung disease (Doyle
et al. 2010). This is explained by a beneficial effect of
steroids on surfactant production and secretion, by
enhanced perinatal lung fluid clearance, by increased
activity of antioxidant enzymes, and by decreased perme-
ability of pulmonary vasculature [for review see (Grier and
Halliday 2004)]. Although beneficial effects of postnatal
steroids on pulmonary outcome have been proven in clin-
ical studies (Doyle et al. 2010), several animal models
raised concerns about their potentially negative impact on
lung development. Administration of low-dose dexameth-
asone (Dex) during 10–14 days beginning as early as
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postnatal days 2–4 in rats inhibited alveolarization with a
long-lasting effect of reduced lung parenchyma complexity
(Blanco et al. 1989; Tschanz et al. 1995). In addition, acute
adverse effects of postnatal steroid treatment including
gastrointestinal bleeding and perforation, neonatal hyper-
tension and hyperglycemia as well as increasing evidence
of a negative impact on long-term outcome (e.g., impaired
neurodevelopment, growth restriction, cerebral palsy) have
dampened their postnatal use over the last years (Eichen-
wald and Stark 2007; Halliday 2004). For these reasons,
there is a trend in clinical practice to use the lowest
effective dose over the shortest possible period (Halliday
2011).
The classic model of alveolarization postulates that a
double-layered alveolar capillary network is required for
formation of new alveoli and that this process ceases when
the alveolar septa have matured by fusion of the micro-
vasculature to a single capillary layer (Burri 2006).
Recently, it was shown in various species including
humans that alveolarization continues until young adult-
hood which is far beyond the maturation of the microvas-
culature (Hyde et al. 2007; Mund et al. 2008; Narayanan
et al. 2012; Schittny et al. 2008). Duplication of the cap-
illary network at the base of newly forming alveolar septa
permits alveolarization even after maturation of the
microvasculature (Schittny et al. 2008). This mechanism
was called late alveolarization. Due to the fact that clas-
sical and late alveolarization may take place in parallel, the
phase during which classical alveolarization is predomi-
nant is now called first phase of alveolarization (postnatal
days 4–21 in rats) and the one with dominantly late alve-
olarization is named second phase of alveolarization (day
14—young adulthood). The overlap of the two phases
emphasizes that classical alveolar formation blends over in
late alveolarization.
In order to mirror the clinical use of neonatal steroids,
we analyzed the effect of the administration of a short
regimen of Dex to newborn rats for only the first four
postnatal days. As shown previously, this resulted in a
marked acceleration of lung vascular maturation at the end
of the treatment period on P4 (Roth-Kleiner et al. 2005;
Tschanz et al. 2003). However, lung development was
delayed with a transient loss of parenchymal complexity
(Schwyter et al. 2003). To the best of our knowledge, the
precise timing of the parenchymal alterations, their corre-
lation to the first and second phase of alveolarization, and
the role of extracellular factors have never been studied.
Therefore, we (1) studied the formation of new alveolar
septa as a measure of alveolarization and (2) analyzed the
temporal and spatial expression of tenascin-C (TNC),
elastin, and smooth muscle actin (SMA)—three factors
involved in alveolarization. Elastin is produced by myofi-
broblasts at the newly forming free septal edge (septal tip
in 2-dimensional lung sections). Elastin and myofibroblasts
are required for the formation of new septa (Bostrom et al.
1996, 2002; Lindahl et al. 1997; McGowan et al. 2008).
TNC is induced by mechanical stress, contributes to the
regulation of cell adhesion, and shows a specific expression
pattern during lung development (Chiquet et al. 2004;
Yamamoto et al. 1999; Young et al. 1994).
Methods
Animals and tissues
All parts of the animal experiments were approved and
supervised by the Swiss Agency for the Environment,
Forests and Landscape and the Veterinary Service of the
Canton of Bern. Newborn Sprague–Dawley male rat pups
were subcutaneously injected with dexamethasone sodium
phosphate (Decadron, Merck Sharp & Dohme AG,
Glattbrugg, Switzerland) on postnatal days P1–P4 (P1:
0.1 mg, P2: 0.05 mg; P3: 0.025 mg; P4: 0.01 mg per kg
body weight) or an equivalent volume of NaCl 0.9 %
(controls). For the stereological measurements and the
visualization of the tissue, lungs were prepared on postnatal
days P4, P6, P10, P21, P36, and P60 according to Schittny
et al. (Corroyer et al. 2002; Schittny et al. 1997, 1998).
Briefly, after applying a pneumothorax, the lungs were
fixed by intratracheal instillation of 4 % paraformaldehyde
in phosphate-buffered saline at a constant pressure of
20 cm H2O water column. The pressure was maintained for
at least 4 h. Thereafter, the volumes of the separated lung
lobes were measured by water displacement, and the lung
volume was calculated (Scherle 1970).
Immunohistochemistry
Tenascin-C (TNC) and SMA double labeling of paraffin
sections were done according to routine protocols (Faber
et al. 1992; Schittny et al. 1995). Briefly, sections were
unmasked with 0.1 % pronase (Roche, Rotkreuz, Switzer-
land) in PBS and blocked with 5 % BSA (bovine serum
albumin) and 1 % newborn goat serum in TRIS-buffered
saline (TBS). Mouse anti-alpha-smooth muscle actin (clone
1A4, Sigma-A-2547, Sigma-Aldrich, Buchs, Switzerland)
was diluted 1:1,000 in blocking solution and applied at
4 C over night. Anti-TNC (rabbit anti-chicken, a gift of
Matthias Chiquet, Bern) was diluted 1:50 in blocking
solution and applied for 1 h at room temperature. Bound
antibodies were visualized using Cy3-labeled affinity-iso-
lated goat anti-rabbit IgG (The Jackson Laboratory, Bar
Harbor, Maine, USA) and Alexa 488 labeled goat anti-
mouse IgG (Molecular Probes, Life Technologies Europe
B.V., Zug, Switzerland) diluted 1:1,000 or 1:500,
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respectively, in TBS containing 5 % BSA for 1 h at room
temperature. Elastin staining was done similarly using
rabbit anti-rat elastin (Chemicon AB2039, Millipore, Zug,
Switzerland), diluted 1:100 for 1 h at room temperature.
Negative controls were performed with non-specific mouse
or rabbit IgG (Luyet et al. 2002). None or only little non-
specific background was observed in all negative controls.
The shown samples were taken from all parts of the lung.
No significant differences between central and peripheral
regions of the lung were observed under all conditions.
Stereology
Estimations were done according to Schittny et al. (2008).
Briefly, the right middle lobes were embedded in paraffin
and 10–13 isotropic uniform random step sections were cut
perpendicular to the longitudinal axis of the lobe, without
special attention to orientation. Sections were stained with
hematoxylin and eosin, and 40–60 images were taken
systematic randomly (Hsia et al. 2010). The volume den-
sity of the lung parenchyma was estimated by point
counting. The absolute parenchymal volume was calcu-
lated as the product of the parenchymal volume density and
the lung volume for each animal and time point (Howard
and Reed 2005). As an approximation for alveolarization,
septation (the formation of new septa) was assessed by
estimating the length of the free septal edge (length of
alveolar entrance rings). Based on the growth of the lung
(increase in lung volume) during development, we calcu-
lated how much of the estimated increase in the length of
the free septal edge is caused purely by growth and how
much is caused by the formation of new septa (Schittny
et al. 2008).
Statistical analysis
For all measurements, 3–5 animals per time point were
used. Data were analyzed using one-way analysis of vari-
ance (ANOVA) coupled with post hoc Duncan test for
multiple pair wise comparisons. Significance level was set
at P \ 0.05.
Synchrotron radiation X-ray tomographic microscopy
(SRXTM)
Lung samples, obtained as described above, were embed-
ded in Epon, milled down to a rod of 1.5 mm as described
recently (Roth-Kleiner et al. 2005), and scanned by a
monochromatic X-ray beam (12.398 keV) at the microto-
mography station of the Materials Science Beamline at the
Swiss Light Source (Paul-Scherrer-Institut, Villigen,
Switzerland) (Schittny et al. 2008). The software Imaris
(Bitplane AG, Zu¨rich, Switzerland) was used for 3D
visualization and surface rendering (Haberthur et al. 2010;
Schittny et al. 2008).
TNC gene expression measurements by qRT-PCR
Tenascin-C (TNC) gene expression was measured in lung
tissue of treated and untreated animals (n = 3–5) on days
P4 and P10, as described recently (Trummer-Menzi et al.
2012). Primer sequences for TNC, identified with Primer-
BLAST software (National Center for Biotechnology
Information; www.ncbi.nlm.nih.gov), are forward: ATG
CAC CCA GGG ACT TAC AG and reverse: GCT TGC
TCT TAT GTC TGC CC.
Results
Histology
Three-dimensional visualization by SRXTM of untreated
rat lungs at postnatal days P4 and P21 (Fig. 1a, c) revealed
the known phenotype of the first phase of alveolarization,
meaning an overall decrease in size of peripheral gas-
exchange units due to subdivision of the large sacculi by
newly formed secondary septa. During the second phase of
alveolarization between days P14 and P60 (Fig. 1c, e), the
formation of new alveolar septa continued, and the com-
plexity of lung parenchyma increased further. While during
the first phase, the formation of new septa/alveoli exceeded
growth of lung volume, this ratio inversed during the sec-
ond phase. As a result, the visual impression of the size
(diameter) of alveoli decreased between days P4 and P21
and increased again between days P21 and P60 (Fig. 1). In
the Dex-treated animals (Fig. 1b, d, f), this process seemed
to be disturbed at P4, as there were larger terminal air-
spaces (Fig. 1b) compared to untreated age-matched con-
trols (Fig. 1a). By day P21, no such difference was
recognizable anymore (Fig. 1c, d). Unexpectedly, smaller
airspaces were observed in the Dex group on day P36,
which indicates an accelerated second phase of alveolar-
ization. On day P60, no difference was observed anymore
(Fig. 1e, f).
Morphometry of septal formation
In order to quantify this visual impression of delayed al-
veolarization, the total length of free septal edges was
estimated (Fig. 2b), and the ‘‘Anlage’’ (formation) of new
septa as an indicator of the ongoing alveolarization process
was calculated (Fig. 2a). As basis for this calculation, we
mathematically distinguished between the increase in the
free septal edges due to the overall growth of the lung
(*10 % of total increase between days P4 and P60) and
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the increase due to the formation of new septa (*90 %). In
control animals, the first phase of alveolarization (P4–P21)
corresponded to a tremendous increase in the total length of
septal edges (Fig. 2b), and a similar increase in newly
formed septa from 100 % set at P4 to 516 % length at P21
(Fig. 2a). Thereafter, formation of new septa continued
into young adulthood (822 %). During this second phase of
alveolarization, an important increase in absolute length of
Fig. 1 Synchrotron radiation X-ray tomographic microscopy images
of alveoli. 3D images of the terminal ends of the airways of rat lungs
between postnatal days P4 to P60 in controls (panels a, c, e) and in
Dex-treated animals (panels b, d, f). Arrows point to uplifted new
secondary septa, which are very abundant on days P4 and P21
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free septal edges took place (P21: 2,067 m; P60: 4,674 m,
Fig. 2b). In Dex-treated rats, the first phase of alveolar-
ization was impaired, manifested as a significantly lower
increase in the total length of free septal edges and a less
abundant formation of new secondary septa at Dex-P6
(150 %) and Dex-P10 (268 %) compared to CTRL
(P6:190 %, P = 0.04; P10: 329 %, P = 0.01) (Fig. 2).
During second phase of alveolarization, however, an
inverse trend was measured in lungs of Dex-treated ani-
mals with accelerated alveolar formation. Dex induced a
statistically significant increase in the total length of the
free septal edges and an acceleration of new septal for-
mation at P36 (P36: 638 %, vs. Dex-P36: 781 %,
P = 0.03; Fig. 2). In young adulthood (P60), this catch-up
alveolar formation had stopped with no differences
between CTRL and Dex-treated animals, neither in total
length of free septal edges nor in the ‘‘Anlage’’ of new
secondary septa.
Immunohistochemistry
Knowing the importance of extracellular matrix (ECM)
proteins and myofibroblasts in the process of uplifting of
new secondary septa, we investigated the time-dependent
expression pattern of TNC, elastin, and SMA (as a marker
for myofibroblasts) by immunohistochemistry. In controls,
TNC was already expressed on P1, typically at the tips of
the newly formed septa, corresponding to the entrance ring
of the alveoli (Fig. 3a). Its expression almost ceased by
P16 (Fig. 3e). SMA showed a strong expression in the
same localization, but appeared later (not present on P1
(Fig. 3a), only on P4 (Fig. 3c) and was still present on P16
(Fig. 3e) and adulthood (data not shown). Due to Dex
treatment, expression of TNC was delayed by 5 days,
appearing not before P6 (Fig. 3b, d); however, its presence
was prolonged in Dex-treated animals, still being visible on
P16 (Fig. 3f). SMA expression pattern was not markedly
changed by Dex (Fig. 3b, d, f).
Elastin fibers in lung tissue could be identified in lung
parenchyma of controls already on P1 (not shown). It was
rarely but evenly distributed over all of the septal walls on
P3 (Fig. 4a) and also in the wall of blood vessels. Its
expression strongly increased until P10 with an expression
pattern shifting toward the tips of newly formed septa
(Fig. 4c, e). In alveolar septa of Dex-treated animals, only
small amounts of elastin were observed at P3 (Fig. 4b). By
P6, the localization of elastin fibers in Dex-treated animals
corresponded more to the phenotype of non-treated con-
trols on P3, with a less important elastin concentration at
the septal tips compared to CTRL (Fig. 4c, d). By P10, no
difference was observed anymore between CTRL and Dex-
treated lungs (Fig. 4e, f).
TNC gene expression
In animals treated with Dex, TNC expression was signifi-
cantly reduced already by P4 compared to CTRL, but no
longer on P10 (Fig. 5).
Discussion
In clinical practice of perinatal medicine, glucocorticoids
hold an important place in the prevention and treatment
for respiratory insufficiency in preterm infants. Their
Fig. 2 ‘‘Anlage of septa’’ and length of free septal edges. The
‘‘anlage’’ of newly forming alveolar septa was calculated by
mathematically distinguishing between the increase in the length of
the free septal edge due to the overall growth of the lung and the
increase due to the formation of new alveolar septa. In panel a, the
anlage of new septa is compared between CTRL (black bars) and
Dex-treated rats (white bars). It is expressed as a percentage of the
initial length of septa in control animals on postnatal day P4
(=100 %). Only the increase in length due to the formation of new
septa is shown. The original data (estimation of total length of septa in
meters) are shown in panel b. *P \ 0.05 comparing CTRL and Dex
of the same day
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beneficial effect on gas exchange by increasing surfactant
production and secretion, their anti-inflammatory proper-
ties on lung capillaries, and the acceleration of lung liquid
absorption are undisputed. However, their impact on lung
structure is more controversial (Banks et al. 2002). We
demonstrate in this study that already a short regimen of
systemic Dex provoked a delay of the start of alveolar-
ization. We were able to show by 3D reconstruction of lung
tissue as well as by stereology, that septal formation, aimed
at subdividing the sacculi into new alveoli with the goal of
increasing gas-exchange surface, was delayed by Dex. By
P6 and P10, we found a significant reduction in the com-
plexity of lung structure in Dex-treated animals compared
to CTRL. Classical alveolarization, today also called first
phase of alveolarization, mainly occurs in rats between P4
and P21 and consists in uplifting of new septal structures at
sites where specific ECM proteins and myofibroblasts are
accumulated (Schittny et al. 2008). We therefore focused
on the effect of Dex on the expression of TNC, elastin, and
SMA. In mammals, TNC shows a specific spatial and
temporal expression pattern with two peaks during lung
development: a first one during airway branching (in rats
Fig. 3 Co-localization of TNC and SMA. Expression of TNC (red
fluorescence) and SMA (green fluorescence) by immunofluorescence
in lung tissue of neonatal rats: in lung parenchyma, TNC and SMA
were both expressed at the tips of alveolar septa. In controls (a, c, e),
TNC appeared already on postnatal day P1 (a). It was detected
*2 days earlier than SMA (c). While TNC was down-regulated on
P16 (e), SMA was still expressed (e). In Dex-treated animals, TNC
expression was delayed by 5 days, appearing only on P6 (d) and
prolonged, because small amounts were still observable on P16 (f),
i.e., 2 days longer than in the controls (e). Bar 50 lm
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between embryonic days E13 and E18) and a second one
during early alveolarization. Thereafter, its expression
decreases to almost non-measurable values (Young et al.
1994). TNC is specifically located at the epithelial–mes-
enchymal interface at sites of airway branching during
morphogenesis of the airways and at the tips of the growing
alveolar septa during early alveolarization (Kaarteenaho-
Wiik et al. 2001; Young et al. 1994; Zhao and Young
1995). Reduction in TNC function by addition of TNC
antiserum to lung explants inhibited the branching process
(Young et al. 1994). We have recently shown that
branching morphogenesis was dramatically hampered in
TNC knockout mice (Roth-Kleiner et al. 2004). In analogy,
we hypothesized that the delaying effect of Dex on early
alveolarization might be due to a down-regulation of TNC
expression. In fact, Dex has been shown to decrease TNC
gene expression in different cell lines including human
lung fibroblasts (Degen et al. 2009; Jagodzinski et al.
2004). We found a transient reduction in TNC gene
expression on P4 and a delayed and decreased appearance
of TNC protein in lungs of Dex-treated rat pups. Addi-
tionally, elastin expression within the lung parenchyma
was delayed. We therefore suspect that the delayed for-
mation of alveolar septa observed in the Dex-treated lungs
Fig. 4 Elastin localization during rat lung development. The expres-
sion of elastin is shown by green immunofluorescence between
postnatal days P3 and P10. In alveolar septa of CTRL (a, c, e), elastin
was present on P3. Its expression increased strongly during the period
studied. In alveolar septa of Dex-treated animals (b, d, f), only small
amounts of elastin were observed before P6. Later, no difference was
detected anymore (e, f). Unspecific red fluorescence was used to
visualize the lung tissue. Bar 20 lm
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might, at least in part, be due to a temporarily suppressed
and delayed expression of ECM proteins. Interestingly,
both sites of specific TNC expression during lung devel-
opment are especially exposed to mechanical strain. During
branching, these forces are provoked by fetal breathing
movements (Schittny et al. 2000) and during alveolariza-
tion by the centripetal uplifting of the growing secondary
septa (Schittny et al. 2008). Taking into account that TNC
expression has been shown to be up-regulated by
mechanical strain, we might suspect that the specific spatial
and temporal distribution pattern of TNC during lung
development is, at least in part, coordinated by mechanical
stimuli (Chiquet et al. 2004; Yamamoto et al. 1999). The
importance of mechanical strain in alveolar formation is
highlighted by the fact, that apart from TNC, other mec-
hano-sensing structures like elastin and myofibroblasts are
essential for the subdivision of the sacculi by newly formed
septa. Accumulation of PDGF-A and PDGF-A-receptor-a
expressing myofibroblasts is essential for septal growth
(Bostrom et al. 1996, 2002; Lindahl et al. 1997). These
cells have been shown to produce elastin (McGowan et al.
2008). Massaro et al. have already shown in the 1980s that
subcutaneous injections of Dex between P4 and P13
impaired saccule septation, hampered alveolar surface
increase, and reduced specifically the volume density of
lipid-ladened fibroblasts; however, the mechanisms
remained unknown (Massaro and Massaro 1986; Massaro
et al. 1985). Our results suggest that the presence of TNC,
elastin, and the myofibroblasts seems to be required to
uplift secondary septa. We therefore suggest that the
combined presence of myofibroblasts, TNC, and elastin is a
prerequisite for early or classical alveolarization.
Recently, an increasing body of evidence has emerged
showing that beside the current model of classical alveo-
larization and microvascular maturation followed by iso-
metric lung growth, there has to be a second phase of
alveolar formation (Hyde et al. 2007; Mund et al. 2008;
Narayanan et al. 2012; Schittny et al. 2008). This late al-
veolarization seems to be distinctly different from classical
alveolarization. Whereas the latter mechanism is dependent
on a preexisting double capillary layer, of which one
capillary layer will be included in the uplifted newly
formed septum, late alveolarization happens after micro-
vascular maturation, i.e., the fusion of the double layer into
one. Most likely, a local duplication of the single-layered
capillary network at the base of the newly forming septa
takes place (Schittny et al. 2008). Furthermore, late alve-
olarization seems to be independent of TNC expression at
the free septal edges, as its expression vanishes in rats at
this site after P14. The exact molecular mechanisms
involved in late alveolarization remains to be elucidated.
Most likely due to a prolonged expression of TNC, we
did not find any difference of lung structure complexity
anymore in Dex-treated animals compared to CTRL by
P21. Indeed, we even found an accelerated septal formation
during late alveolarization on day P36. Whether this
compensatory catch-up septal formation in Dex-treated
animals represents an acceleration of the physiological late
alveolarization or a regenerative process after early Dex
treatment might be a semantic question. However, these
results demonstrate that Dex-administration during the
saccular stage has a profound effect on lung development,
although the resulting lung structure in adulthood seems to
be unaltered. Whether all these structural changes during
lung development have an impact on lung function would
be very interesting to investigate, but was out of the scope
of this study. In recent years, there has been increasing
evidence that alveolarization and vascular formation are
connected. We and others have recently shown that Dex
interferes with vascular formation by decreasing VEGF-R2
and by accelerating microvascular maturation (Massaro
and Massaro 2004; Roth-Kleiner et al. 2005). Therefore,
we focused in this study on the investigation of structural
elements involved in the formation of the airspaces.
In conclusion, even a short course of Dex-administration
during the saccular stage of lung development delays the
first phase of alveolarization (classical alveolarization).
This delay includes the suppression of key elements nec-
essary for alveolarization, i.e., the expression of TNC and
elastin. Catch-up alveolar formation, however, is possible
if steroid treatment is of short duration. It takes place in
both phases of alveolarization: as an extended expression
of TNC (first phase) and a higher rate of newly forming
septa during second phase.
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